PPSG
BMY icon

Princeton Portfolio Strategies Group’s Bristol-Myers Squibb BMY Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.54M Sell
23,044
-7,125
-24% -$465K 0.3% 71
2021
Q1 		$1.91M Sell
30,169
-750
-2% -$46.7K 0.37% 70
2020
Q4 		$1.92M Buy
30,919
+714
+2% +$43.9K 0.38% 64
2020
Q3 		$1.82M Sell
30,205
-1,350
-4% -$81.3K 0.4% 57
2020
Q2 		$1.85M Hold
31,555
– – 0.44% 60
2020
Q1 		$1.76M Sell
31,555
-64
-0.2% -$3.91K 0.51% 53
2019
Q4 		$2.03M Buy
31,619
+2,870
+10% +$164K 0.48% 58
2019
Q3 		$1.46M Hold
28,749
– – 0.36% 67
2019
Q2 		$1.3M Buy
28,749
+350
+1% +$16.3K 0.33% 78
2019
Q1 		$1.35M Buy
28,399
+1,722
+6% +$85.8K 0.36% 70
2018
Q4 		$1.39M Sell
26,677
-9,150
-26% -$492K 0.43% 60
2018
Q3 		$2.22M Sell
35,827
-1,500
-4% -$89K 0.58% 52
2018
Q2 		$2.07M Sell
37,327
-9,100
-20% -$491K 0.6% 56
2018
Q1 		$2.94M Sell
46,427
-100
-0.2% -$6.43K 0.83% 42
2017
Q4 		$2.85M Sell
46,527
-100
-0.2% -$6.25K 0.78% 47
2017
Q3 		$2.97M Hold
46,627
– – 0.8% 44
2017
Q2 		$2.6M Sell
46,627
-240
-0.5% -$13.1K 0.74% 46
2017
Q1 		$2.55M Buy
46,867
+3,115
+7% +$171K 0.76% 44
2016
Q4 		$2.56M Buy
43,752
+775
+2% +$42.4K 0.81% 44
2016
Q3 		$2.32M Buy
42,977
+9,912
+30% +$637K 0.73% 49
2016
Q2 		$2.43M Sell
33,065
-100
-0.3% -$7.07K 0.79% 47
2016
Q1 		$2.12M Sell
33,165
-600
-2% -$37.8K 0.72% 48
2015
Q4 		$2.32M Buy
33,765
+1,500
+5% +$99.1K 0.82% 46
2015
Q3 		$1.91M Buy
32,265
+735
+2% +$46.6K 0.78% 48
2015
Q2 		$2.1M Buy
31,530
+6,180
+24% +$407K 0.74% 51
2015
Q1 		$1.64M Sell
25,350
-1,000
-4% -$62.6K 0.63% 58
2014
Q4 		$1.55M Sell
26,350
-50
-0.2% -$2.82K 0.62% 60
2014
Q3 		$1.35M Buy
26,400
+1,650
+7% +$82.4K 0.57% 64
2014
Q2 		$1.2M Buy
24,750
+8,950
+57% +$441K 0.51% 66
2014
Q1 		$821K Sell
15,800
-50
-0.3% -$2.66K 0.54% 66
2013
Q4 		$842K Buy
15,850
+1,350
+9% +$68.8K 0.57% 65
2013
Q3 		$671K Buy
14,500
+800
+6% +$35.1K 0.49% 70
2013
Q2 		$612K Buy
+13,700
New +$595K 0.5% 68

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Princeton Portfolio Strategies Group's BMY Position: Q2 2021 in Review

Princeton Portfolio Strategies Group reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q2 2021, selling an estimated $465K and leaving 23,044 shares worth $1.54M. The position accounts for 0.3% of the portfolio, ranked #71.

Princeton Portfolio Strategies Group first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.97M in Q3 2017. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Princeton Portfolio Strategies Group held 23,044 shares of Bristol-Myers Squibb worth $1.54M as of Q2 2021.
  • Princeton Portfolio Strategies Group sold 7,125 Bristol-Myers Squibb shares in Q2 2021, an estimated $465K.
  • Bristol-Myers Squibb made up 0.3% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #71 holding.
  • Princeton Portfolio Strategies Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
  • Princeton Portfolio Strategies Group's Bristol-Myers Squibb position peaked at $2.97M in Q3 2017.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.